{"title":"AAIC® Satellite Symposium slated for May 14 to 15 in Lima, Peru","authors":"","doi":"10.1002/alz.14569","DOIUrl":null,"url":null,"abstract":"<p>Hosted in collaboration with the Global Brain Health Institute (GBHI) and the Atlantic Fellows for Equity in Brain Health, the annual Alzheimer's Association International Conference<sup>®</sup> (AAIC<sup>®</sup>) Satellite Symposium will take place May 14 to 15 in Lima, Peru, and online.</p><p>The AAIC Satellite Symposium convenes local and international leaders to discuss brain health and dementia risk; developments in clinical research; the role of psychosocial, care, and non-pharmacological interventions in Alzheimer's and other dementias; epidemiology; advances in biomarkers; emerging areas of investigation; and more in a particular region of the world. Previous symposia brought key elements of AAIC to Mexico, Argentina, Bulgaria, India, Brazil, South Africa, and Australia.</p><p>There is widespread recognition that the unique cultural, demographic, and economic characteristics of individual countries demand country- and culture-specific plans to address the burden of the disease and gaps in research. By more broadly sharing locally conducted research and statistics at events such as the AAIC Satellite Symposium, the international research community can better collaborate and find commonalities.</p><p>Also promoting understanding will be the numerous abstracts to be featured at the symposium. Abstract themes will include basic science and pathogenesis, biomarkers, clinical manifestations, public health, drug development, and dementia care. Abstracts will be considered for posters or lightning talks. As part of the abstract submission process, presenting authors may apply for a conference fellowship. Full (registration, airfare, and housing) and partial packages will be awarded based on application materials and financial need.</p><p>Satellite Symposium details, including the program and how to register, will be available soon at alz.org.</p><p>The Alzheimer's Association is committed to supporting global research initiatives through convening, funding, and advocating on behalf of the international research community. We are dedicated to identifying ways the global Alzheimer's research community can collaborate across international borders toward the mutual goal of finding better methods of treatment, prevention, and, ultimately, a cure.</p><p>The Alzheimer's Association, the Global Brain Health Institute (GBHI), and the UK-based Alzheimer's Society have announced the newest recipients of the Pilot Awards for Global Brain Health Leaders, a competitive funding initiative dedicated to fostering leadership in brain health and dementia care.</p><p>“Alzheimer's disease and other dementia are growing global health issues,” said Stefania Forner, PhD, Alzheimer's Association director of medical and scientific relations. As such, local customs and culture, attitudes and perceptions regarding health and disease, and available resources and health systems all must be taken into account in the development of effective dementia-related interventions, services and care.</p><p>“The Alzheimer's Association and its partners, including GBHI and the Alzheimer's Society, are deeply committed to supporting local health and science leaders around the world and their innovative strategies tailored to meet specific community needs — both for immediate care and long-term resilience. This helps ensure that dementia care is accessible, sustainable and effective,” said Forner.</p>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 1","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.14569","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/alz.14569","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Hosted in collaboration with the Global Brain Health Institute (GBHI) and the Atlantic Fellows for Equity in Brain Health, the annual Alzheimer's Association International Conference® (AAIC®) Satellite Symposium will take place May 14 to 15 in Lima, Peru, and online.
The AAIC Satellite Symposium convenes local and international leaders to discuss brain health and dementia risk; developments in clinical research; the role of psychosocial, care, and non-pharmacological interventions in Alzheimer's and other dementias; epidemiology; advances in biomarkers; emerging areas of investigation; and more in a particular region of the world. Previous symposia brought key elements of AAIC to Mexico, Argentina, Bulgaria, India, Brazil, South Africa, and Australia.
There is widespread recognition that the unique cultural, demographic, and economic characteristics of individual countries demand country- and culture-specific plans to address the burden of the disease and gaps in research. By more broadly sharing locally conducted research and statistics at events such as the AAIC Satellite Symposium, the international research community can better collaborate and find commonalities.
Also promoting understanding will be the numerous abstracts to be featured at the symposium. Abstract themes will include basic science and pathogenesis, biomarkers, clinical manifestations, public health, drug development, and dementia care. Abstracts will be considered for posters or lightning talks. As part of the abstract submission process, presenting authors may apply for a conference fellowship. Full (registration, airfare, and housing) and partial packages will be awarded based on application materials and financial need.
Satellite Symposium details, including the program and how to register, will be available soon at alz.org.
The Alzheimer's Association is committed to supporting global research initiatives through convening, funding, and advocating on behalf of the international research community. We are dedicated to identifying ways the global Alzheimer's research community can collaborate across international borders toward the mutual goal of finding better methods of treatment, prevention, and, ultimately, a cure.
The Alzheimer's Association, the Global Brain Health Institute (GBHI), and the UK-based Alzheimer's Society have announced the newest recipients of the Pilot Awards for Global Brain Health Leaders, a competitive funding initiative dedicated to fostering leadership in brain health and dementia care.
“Alzheimer's disease and other dementia are growing global health issues,” said Stefania Forner, PhD, Alzheimer's Association director of medical and scientific relations. As such, local customs and culture, attitudes and perceptions regarding health and disease, and available resources and health systems all must be taken into account in the development of effective dementia-related interventions, services and care.
“The Alzheimer's Association and its partners, including GBHI and the Alzheimer's Society, are deeply committed to supporting local health and science leaders around the world and their innovative strategies tailored to meet specific community needs — both for immediate care and long-term resilience. This helps ensure that dementia care is accessible, sustainable and effective,” said Forner.
期刊介绍:
Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.